{
    "ticker": "TWST",
    "name": "Twist Bioscience Corporation",
    "description": "Twist Bioscience Corporation is a leading synthetic biology company that is revolutionizing the field of biotechnology through its innovative DNA synthesis technology. Founded in 2013, Twist is dedicated to enabling the advancement of life sciences and biotechnology by providing high-quality, high-throughput DNA synthesis services. The company's proprietary platform allows for the rapid and cost-effective synthesis of DNA at scale, making it possible for researchers and companies to accelerate their projects in genomics, therapeutics, and synthetic biology. Twist's diverse product offerings include synthetic genes, DNA libraries, and custom oligonucleotide synthesis, catering to a wide range of applications including drug discovery, agricultural biotechnology, and molecular diagnostics. By harnessing the power of DNA, Twist aims to facilitate breakthroughs in areas such as personalized medicine, sustainable agriculture, and environmental conservation. The company is committed to driving innovation and supporting scientific research that contributes to a healthier and more sustainable world.",
    "industry": [
        "Biotechnology",
        "Synthetic Biology"
    ],
    "headquarters": "San Francisco, California, USA",
    "founded": "2013",
    "website": "https://www.twistbioscience.com",
    "ceo": "Emily M. Leproust",
    "social_media": {
        "twitter": "https://twitter.com/twistbioscience",
        "linkedin": "https://www.linkedin.com/company/twist-bioscience/"
    },
    "investor_relations": "https://investors.twistbioscience.com",
    "key_executives": [
        {
            "name": "Emily M. Leproust",
            "position": "CEO"
        },
        {
            "name": "James E. McCauley",
            "position": "CFO"
        }
    ],
    "product_categories": [
        {
            "category": "DNA Synthesis",
            "products": [
                "Synthetic Genes",
                "DNA Libraries",
                "Custom Oligonucleotides"
            ]
        },
        {
            "category": "Applications",
            "products": [
                "Drug Discovery",
                "Agricultural Biotechnology",
                "Molecular Diagnostics"
            ]
        }
    ],
    "seo": {
        "meta_title": "Twist Bioscience Corporation | Innovating DNA Synthesis",
        "meta_description": "Discover Twist Bioscience, a leader in synthetic biology and DNA synthesis. Explore innovative products and solutions that advance biotechnology and life sciences.",
        "keywords": [
            "Twist Bioscience",
            "Synthetic Biology",
            "DNA Synthesis",
            "Biotechnology",
            "Genomics",
            "Therapeutics"
        ]
    },
    "faq": [
        {
            "question": "What does Twist Bioscience specialize in?",
            "answer": "Twist Bioscience specializes in synthetic biology and DNA synthesis technology."
        },
        {
            "question": "Who is the CEO of Twist Bioscience?",
            "answer": "Emily M. Leproust is the CEO of Twist Bioscience Corporation."
        },
        {
            "question": "Where is Twist Bioscience headquartered?",
            "answer": "Twist Bioscience is headquartered in San Francisco, California, USA."
        },
        {
            "question": "What are the main products offered by Twist Bioscience?",
            "answer": "Twist Bioscience's main products include synthetic genes, DNA libraries, and custom oligonucleotides."
        },
        {
            "question": "When was Twist Bioscience founded?",
            "answer": "Twist Bioscience was founded in 2013."
        }
    ],
    "competitors": [
        "AMRS",
        "SGEN",
        "MGEN",
        "ILMN"
    ],
    "related_stocks": [
        "ABT",
        "VRTX",
        "REGN",
        "BMY"
    ]
}